Search

everythinglearnresearchcommunity

for

Search:↓

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Pranlukast and mirabegron may work as new diabetes drugs.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

GLP-1 agonists may increase the risk of hair loss.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Medications for PCOS don't seem to raise heart disease risk.

The method accurately detects diabetes with 94% effectiveness, reducing misdiagnosis risk.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Linagliptin slows down premature aging in certain mice.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.